Go Pro
→ Why This Small AI Company Holds 150 Patents (From Brownstone Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cuprina Holdings (Cayman) LTD stock logo
CUPR
Cuprina Holdings (Cayman)
$1.87
-1.6%		$2.89
$1.45
▼
$14.80
$13.31M-0.37140,843 shs7,083 shs
Innovative Eyewear, Inc. stock logo
LUCYW
Innovative Eyewear
$0.04
$0.04
$0.03
▼
$0.18
N/AN/A9,932 shsN/A
NexGel, Inc. stock logo
NXGL
NexGel
$0.17
-33.6%		$0.36
$0.16
▼
$2.89
$2.55M0.76216,914 shs3.59 million shs
NEXGEL, Inc. stock logo
NXGLW
NEXGEL
$0.01
$0.02
$0.01
▼
$0.34
N/AN/A12,498 shs7,574 shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cuprina Holdings (Cayman) LTD stock logo
CUPR
Cuprina Holdings (Cayman)
-1.58%+4.47%-36.39%-64.92%+186,999,900.00%
Innovative Eyewear, Inc. stock logo
LUCYW
Innovative Eyewear
0.00%+15.08%-18.56%-0.57%-71.92%
NexGel, Inc. stock logo
NXGL
NexGel
-33.59%-34.54%-51.12%-66.53%-92.81%
NEXGEL, Inc. stock logo
NXGLW
NEXGEL
-8.15%-4.62%-31.11%-58.94%-95.99%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cuprina Holdings (Cayman) LTD stock logo
CUPR
Cuprina Holdings (Cayman)
$1.87
-1.6%		$2.89
$1.45
▼
$14.80
$13.31M-0.37140,843 shs7,083 shs
Innovative Eyewear, Inc. stock logo
LUCYW
Innovative Eyewear
$0.04
$0.04
$0.03
▼
$0.18
N/AN/A9,932 shsN/A
NexGel, Inc. stock logo
NXGL
NexGel
$0.17
-33.6%		$0.36
$0.16
▼
$2.89
$2.55M0.76216,914 shs3.59 million shs
NEXGEL, Inc. stock logo
NXGLW
NEXGEL
$0.01
$0.02
$0.01
▼
$0.34
N/AN/A12,498 shs7,574 shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cuprina Holdings (Cayman) LTD stock logo
CUPR
Cuprina Holdings (Cayman)
-1.58%+4.47%-36.39%-64.92%+186,999,900.00%
Innovative Eyewear, Inc. stock logo
LUCYW
Innovative Eyewear
0.00%+15.08%-18.56%-0.57%-71.92%
NexGel, Inc. stock logo
NXGL
NexGel
-33.59%-34.54%-51.12%-66.53%-92.81%
NEXGEL, Inc. stock logo
NXGLW
NEXGEL
-8.15%-4.62%-31.11%-58.94%-95.99%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cuprina Holdings (Cayman) LTD stock logo
CUPR
Cuprina Holdings (Cayman)
1.00
SellN/AN/A
Innovative Eyewear, Inc. stock logo
LUCYW
Innovative Eyewear
0.00
N/AN/AN/A
NexGel, Inc. stock logo
NXGL
NexGel
1.50
Reduce$2.001,049.43% Upside
NEXGEL, Inc. stock logo
NXGLW
NEXGEL
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest CUPR, NXGL, LUCYW, and NXGLW Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/26/2026
Cuprina Holdings (Cayman) LTD stock logo
CUPR
Cuprina Holdings (Cayman)
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
8/24/2026
NexGel, Inc. stock logo
NXGL
NexGel
Maxim Group logo
Maxim Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold
8/11/2026
Cuprina Holdings (Cayman) LTD stock logo
CUPR
Cuprina Holdings (Cayman)
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
7/17/2026
Cuprina Holdings (Cayman) LTD stock logo
CUPR
Cuprina Holdings (Cayman)
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/13/2026
NexGel, Inc. stock logo
NXGL
NexGel
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
(Data available from 9/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cuprina Holdings (Cayman) LTD stock logo
CUPR
Cuprina Holdings (Cayman)
$40K327.25N/AN/A$1.50 per share1.25
Innovative Eyewear, Inc. stock logo
LUCYW
Innovative Eyewear
$3.41MN/AN/AN/AN/AN/A
NexGel, Inc. stock logo
NXGL
NexGel
$11.42M0.15N/AN/A$0.60 per share0.29
NEXGEL, Inc. stock logo
NXGLW
NEXGEL
$12.07MN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cuprina Holdings (Cayman) LTD stock logo
CUPR
Cuprina Holdings (Cayman)
-$3.63MN/AN/AN/AN/AN/AN/AN/AN/A
Innovative Eyewear, Inc. stock logo
LUCYW
Innovative Eyewear
N/AN/AN/AN/AN/AN/AN/AN/A11/12/2026 (Estimated)
NexGel, Inc. stock logo
NXGL
NexGel
-$3M-$0.71N/AN/AN/A-51.26%-121.18%-41.15%11/10/2026 (Estimated)
NEXGEL, Inc. stock logo
NXGLW
NEXGEL
N/AN/AN/AN/AN/AN/AN/AN/A11/17/2026 (Estimated)

Latest CUPR, NXGL, LUCYW, and NXGLW Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
NexGel, Inc. stock logo
NXGL
NexGel
-$0.12-$0.40-$0.28-$0.40$4.32 million$3.69 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Cuprina Holdings (Cayman) LTD stock logo
CUPR
Cuprina Holdings (Cayman)
N/AN/AN/AN/AN/A
Innovative Eyewear, Inc. stock logo
LUCYW
Innovative Eyewear
N/AN/AN/AN/AN/A
NexGel, Inc. stock logo
NXGL
NexGel
N/AN/AN/AN/AN/A
NEXGEL, Inc. stock logo
NXGLW
NEXGEL
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cuprina Holdings (Cayman) LTD stock logo
CUPR
Cuprina Holdings (Cayman)
0.07
2.35
2.35
Innovative Eyewear, Inc. stock logo
LUCYW
Innovative Eyewear
N/AN/AN/A
NexGel, Inc. stock logo
NXGL
NexGel
0.68
0.43
0.27
NEXGEL, Inc. stock logo
NXGLW
NEXGEL
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Cuprina Holdings (Cayman) LTD stock logo
CUPR
Cuprina Holdings (Cayman)
N/A
Innovative Eyewear, Inc. stock logo
LUCYW
Innovative Eyewear
N/A
NexGel, Inc. stock logo
NXGL
NexGel
2.21%
NEXGEL, Inc. stock logo
NXGLW
NEXGEL
N/A

Insider Ownership

CompanyInsider Ownership
Cuprina Holdings (Cayman) LTD stock logo
CUPR
Cuprina Holdings (Cayman)
N/A
Innovative Eyewear, Inc. stock logo
LUCYW
Innovative Eyewear
N/A
NexGel, Inc. stock logo
NXGL
NexGel
19.79%
NEXGEL, Inc. stock logo
NXGLW
NEXGEL
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Cuprina Holdings (Cayman) LTD stock logo
CUPR
Cuprina Holdings (Cayman)
107.00 millionN/AN/A
Innovative Eyewear, Inc. stock logo
LUCYW
Innovative Eyewear
9N/AN/ANot Optionable
NexGel, Inc. stock logo
NXGL
NexGel
199.75 million7.82 millionNot Optionable
NEXGEL, Inc. stock logo
NXGLW
NEXGEL
19N/AN/ANot Optionable

Recent News About These Companies

NEXGEL, Inc. (NASDAQ:NXGLW) Short Interest Update
September 25 at 4:53 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31048592
NEXGEL Announces Dial-In Details for Investor Update Call
September 23 at 9:29 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/23/3367560/0/en/nexgel-announces-dial-in-details-for-investor-update-call.html
NEXGEL Announces Date for Investor Update Call
September 16, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/16/3363269/0/en/nexgel-announces-date-for-investor-update-call.html
NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18th
June 4, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/04/3306817/0/en/nexgel-to-present-at-planet-microcap-conference-las-vegas-on-june-16th-18th.html
NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration
May 19, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/19/3297580/0/en/nexgel-reports-positive-data-from-randomized-single-center-irb-study-to-evaluate-the-effectiveness-and-safety-of-a-hydrogel-laser-treatment-patch-in-laser-hair-removal-with-a-95-6-.html
NEXGEL Strengthens Board with Sequence LifeScience Leaders
May 12, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/nexgel-strengthens-board-with-sequence-lifescience-leaders?utm_source=marketbeat.com&utm_medium=referral
NEXGEL To Report First Quarter 2026 Financial Results on May 15th
May 12, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/12/3293080/0/en/nexgel-to-report-first-quarter-2026-financial-results-on-may-15th.html
NexGel Acquires Celularity Regenerative Biomaterials in Transformative Deal
March 10, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/nexgel-acquires-celularity-regenerative-biomaterials-in-transformative-deal?utm_source=marketbeat.com&utm_medium=referral
NexGel Secures Convertible Note Financing for Acquisition
February 11, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/nexgel-secures-convertible-note-financing-for-acquisition?utm_source=marketbeat.com&utm_medium=referral
NexGel Inc Reports Q3 2025 Financial Results
November 12, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/nexgel-inc-reports-q3-2025-financial-results?utm_source=marketbeat.com&utm_medium=referral
NEXGEL, Inc. Reports Steady Q3 2025 Performance
November 11, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/nexgel-inc-reports-steady-q3-2025-performance?utm_source=marketbeat.com&utm_medium=referral
NexGel Inc Appoints Steven Ciardiello to Board
August 5, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/nexgel-inc-appoints-steven-ciardiello-to-board?utm_source=marketbeat.com&utm_medium=referral

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cuprina Holdings (Cayman) stock logo

Cuprina Holdings (Cayman) NASDAQ:CUPR

$1.87 -0.03 (-1.58%)
Closing price 09/25/2026 04:00 PM Eastern
Extended Trading
$1.85 -0.02 (-0.86%)
As of 09/25/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. We believe we will be able to build upon and leverage such expertise to develop innovative cosmeceutical products in the future. As of June 30, 2024, we manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement. In addition to our currently commercialized MEDIFLY products, we have two lines of chronic wound care products in our pipeline. Such lines of pipeline chronic wound care products include: . Collagen dressings, including sponges, particles and hydrogels utilizing bullfrog collagen derived from the valorization of abattoir waste streams of American bullfrogs (Lithobates catesbeianus); and . Products utilizing medical leeches for wound treatment. We currently expect development of such products to take place over the course of 2025 and 2026 and to become commercially available subject to regulatory approval. However, we may not be able to successfully develop the aforementioned pipeline products on the timeline currently envisioned, or at all, and even if we do, these products may not receive the necessary regulatory approvals from the authorities in the intended markets where we plan to introduce them. We believe what sets us apart is our focus on developing functionally specific chronic wound care products designed to address the major stages of wound healing process, from chronic to closure. Our chronic wound care products, including both our existing commercialized products and forthcoming products in our pipeline, are poised to benefit from escalating global market demand. This demand is primarily fueled by the demographic shift towards an aging population and the concurrent rise in comorbidities such as diabetes, obesity, cardiovascular ailments, and peripheral vascular diseases. We either self-develop our chronic wound care products or co-develop them through technology licensing agreements or research collaboration with a renowned research university. In June 2022, we were granted an exclusive license from NTUitive Pte. Ltd., a wholly owned subsidiary of Nanyang Technological University, to develop and commercialize a range of chronic wound care products using collagen derived from bullfrog skin. In addition, in August 2022, we entered into an industry research collaboration agreement with Nanyang Technological University, or, together with its subsidiaries, NTU, pursuant to which both parties agreed to jointly undertake a research project regarding the development and validation of bullfrog skin waste to generate collagen-based wound care products. We have been selling our MEDIFLY products primarily in Singapore since February 2020. In March 2023, our MEDIFLY products became commercially available in Hong Kong. Looking ahead, we have strategic plans in place for 2025 and 2026 to expand our sales and establish physical operations in several key regions, including the Middle East (in particular, the member states of the Gulf Cooperation Council, or GCC), and mainland China. These expansion initiatives will further enable us to cater to the growing demand for our products in these promising markets, cementing our position as a trusted player in the field of chronic wound care and treatment. For our cosmeceuticals business, we introduced three products in 2023, including a hydrating balm product, a muscle energy cream and a pain relief muscle patch. For our currently commercialized cosmeceutical products, we have commissioned original equipment manufacturers of skincare products to develop the formulation and manufacture the substantially finished and finished products. In addition, we plan to explore the possibility of developing a range of potential cosmeceutical product candidates incorporating bullfrog collagen with a view to making them commercially available between 2025 and 2028, subject to the progress of the relevant R&D work. We offer our chronic wound care products to both public and private hospitals and clinics, where patients can obtain them through prescription from a physician. Our customers primarily include major public and private hospitals and clinics in Singapore. Our commercialized cosmeceutical products can be purchased directly by individual customers through a variety of channels, including retailers and gyms in Singapore and other countries such as Malaysia and Australia, as well as online shopping platforms such as Shopee. Our commitment to quality is demonstrated by our attainment of ISO 13485:2016 standards for Quality Management Systems and Manufacturing Processes and Controls for our manufacturing facility located in Singapore in 2020. We are working towards obtaining compliance with 21 CFR Part 820, an integral component of the Current Good Manufacturing Practice, or CGMP, regulations, to secure FDA 510(k) clearance for our chronic wound care products, including both our existing commercialized products and forthcoming products in our pipeline. Our principal executive office is in Singapore.

Innovative Eyewear stock logo

Innovative Eyewear NASDAQ:LUCYW

$0.04 0.00 (0.00%)
As of 09/25/2026

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform various smartphone tasks hands-free. It also offers smart eyewear under the Lyte XL brand; and Nautica Powered by Lucyd smart eyewear collection and various branded accessories, including a power brick, cleaning cloth, and a slipcase adorned. In addition, the company provides Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with an individual's voice; and Lucyd app for iOS and Android to provide voice access to ChatGPT in Lucyd eyewear. It sells its products through various e-commerce and retail channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida.

NexGel stock logo

NexGel NASDAQ:NXGL

$0.17 -0.09 (-33.59%)
Closing price 09/25/2026 04:00 PM Eastern
Extended Trading
$0.18 +0.00 (+0.57%)
As of 09/25/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.

NEXGEL stock logo

NEXGEL NASDAQ:NXGLW

$0.01 0.00 (0.00%)
As of 09/25/2026 12:33 PM Eastern
This is a fair market value price provided by Massive. Learn more.

NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments, Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications under the MedaGel brand; and beauty and cosmetic solutions, such as wrinkle and skin cream applications under the LumaGel Beauty brand name. It is also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas